GE HealthCare is researching imaging tech for improved diagnosis and treatment of patients with cancer and neurodegenerative ...

The researchers identified one imaging method that was more accurate ... Phase II clinical trial evaluating an immunotherapy for brain cancer. They took into consideration the patient's response ...

A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 ...

A pioneering new treatment promises to tackle a wider range of cancers, with fewer side-effects than conventional ...

Combining microbeam radiotherapy with targeted radiosensitizers could treat tumours while sparing normal brain tissues ...

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI ...

We identified one imaging method that was more accurate ... center phase 2 clinical trial evaluating an immunotherapy for brain cancer. We took into consideration the patient’s response to ...

The spread of metastatic brain cancer presents one of the most challenging hurdles in oncology, as it often leads to poor ...

A new therapy for the most aggressive type of brain cancer can extend patients ... In the new trial, the researchers added another type of imaging, called 18F-DOPA PET. It's a kind of positron ...

The AI system analyzes MRI scans to identify the spread of cancer cells into surrounding brain tissue, achieving 85% accuracy ...

A London, Ont., teenager with brain cancer and her family will have to travel to the United States to receive a cutting-edge ...